PerkinElmer Acquiring German Company for $30M
Health sciences company PerkinElmer Inc. today announced it is acquiring Evotec Technologies GmbH in a cash transaction valued at approximately $30 million.
Based in Hamburg, Germany, Evotec Technologies, a subsidiary of Evotec AG, provides high performance screening instrumentation and analysis software for cellular screening, a critical tool for drug discovery, PerkinElmer said.
“Our customers today require unique, flexible tools and platforms that produce better quality and biologically relevant data for mapping cellular events to new discoveries,” said Gregory L. Summe, PerkinElmer chairman and CEO.
Evotec Technologies’ Opera HCS platform for high-content analysis combines confocal microscopy with the throughput required for primary and secondary screening. The company's product line also includes high-content cellular analysis and screening systems; cell manipulation and sorting systems; image capture and cellular analysis software; and integrated ultrahigh throughput screening platforms.
The transaction is subject to regulatory approvals and other customary closing conditions, and is expected to be completed in the first quarter of 2007, PerkinElmer said. For more information, visit:
www.perkinelmer.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024